Naslov
Treatment with risperidone in earlyonset of psychotic decompensations in adolescents

Autori
Graovac, Mirjana ; Petrić, Daniela ; Kaštelan, Ana ; Frančišković, Tanja ; Moro, Ljiljana

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
Abstracts of the 8th ECNP Regional Meeting ; u: European Neuropsychopharmacology 15 (2005) (S2) S87-S312 ; Psychotic disorder and antipsychotic, P.2.020 / - : Elsevier, 2005, 138-139

Skup
ECNP Regional Meeting (8 ; 2005)

Mjesto i datum
Moskva, Ruska Federacija, 04.2005

Vrsta sudjelovanja
Poster

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
risperidone; adolescents; psychosis

Sažetak
This study shows our experience of the treatment with risperidone in early onset of psychotic decompensation in adolescents. Methods: This was a six-months, follow up study. A sample of 22 adolescents (18 male and 4 female), aged 11-22, mean age 15.5 years were treated with risperidone. Adolescents were divided into two groups ; 11-16 (12 male and 3 female) and 18-22 years (6 male and 1 female), according to developmental phases of adolescence. Adolescents with early onset of psychotic decompensations were diagnosed by using ICD X criteria. Treatment with risperidone was analysed using PANSS and CGI scale on the day of introduction of risperidon, one month and six months later. Summary of Results: The study indicates that the usage of average daily dose of risperidone was 2.07mg (min. 1 mg ; max. 4mg) in the subgroup of 11-16 years old adolescents, while in the subgroup of 18-22 years old adolescents it was 4.43 mg. Significant reductions on PANSS scale and significant decreases in CGI scores severity of illness and improvement has been found within one and six months of the treatment in both analyzed subgroups of adolescents. Conclusions: Our clinical experience showed that risperidone significantly decreased psychotic symptoms in both subgroups of adolescents. Younger adolescents needed less average daily dose of risperidone (2.07mg)than older adolescents (4.43 mg).

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti

POVEZANOST RADA